Background: Little is known about the clinical and prognostic impact of early repolarization (ER) on patients with Brugada syndrome (BrS), especially those with documented ventricular fibrillation (VF).
Objective: To investigate the prevalence and prognostic significance of ER in inferolateral leads in patients with BrS and documented VF.
Methods: We investigated 10 different 12-lead electrocardiograms (ECGs) recorded on different days to identify the presence of ER, which was defined as J-point elevation ≥0.1 mV in inferior (II, III, aVF) or lateral leads (I, aVL, V₄-V₆), in 49 individuals (46 men; age 46 ± 13 years) with a type 1 ECG of BrS and previous history of VF.
Results: ER was observed persistently (in all ECGs) in 15 patients (31%; P group), intermittently (in at least one but not in all ECGs) in 16 patients (33%; I group), and not observed in 18 patients (37%; N group), yielding an overall ER incidence of 63% (31/49). During the follow-up period (7.7 years), recurrence of VF was documented in all 15 patients (100%) in the P group, and less in 12 patients (75%) in the I group and in 8 patients (44%) in the N group. The P group showed a worse prognosis than N group (P = .0001) by Kaplan-Meier analysis. Either persistent or intermittent ER in an inferolateral lead was an independent predictor of fatal arrhythmic events (hazard ratio 4.88, 95% confidence interval 2.02-12.7, P = .0004; and hazard ratio 2.50, 95% confidence interval 1.03-6.43, P = .043, respectively).
Conclusion: The prevalence of ER in inferolateral leads was high and an especially persistent form of ER was associated with a worse outcome in BrS patients with documented VF.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.hrthm.2013.04.009 | DOI Listing |
Introduction: A novel focal lattice tip catheter allowing the delivery of either pulsed field (PF) or radiofrequency (RF) energy has recently received regulatory approval. The technology features a proprietary 3D electroanatomical mapping system.
Objective: to describe the first real-world and multicentre experience.
Open Access Emerg Med
December 2024
Emergency Department, Lucerne Cantonal Hospital and University of Lucerne, Lucerne, Switzerland.
Background: ST elevation combined with typical chest pain is an indication for acute coronary vascularization and is usually associated with acute myocardial infarction. Herein, we present an unusual case of ST elevation.
Case Presentation: A 57-year-old male patient presented to the emergency department with chest pain radiating to both arms and the back.
J Cardiovasc Echogr
September 2024
Department of Cardio-Thoracic-Vascular and Public Health, Cardiology Unit, Padova University Hospital, Padova, Italy.
Cardiol Young
September 2024
Paediatric Cardiology and Cardiac Arrhythmias Unit, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
Introduction: The presence of T wave inversion on screening electrocardiogram may represent an early sign of cardiomyopathies in athletes. This finding even in very young athletes can generate some suspicion and may determine a contraindication to practice competitive sport. The aim of this study is to evaluate the prevalence of T wave inversion in a population of young competitive athletes and determine whether they can be associated with the occurrence of cardiomyopathies in the absence of other pathological features.
View Article and Find Full Text PDFBr J Cardiol
November 2023
Consultant Department of Cardiology, Hull University Teaching Hospitals NHS Trust, Castle Hill Hospital, Castle Road, Cottingham, HU16 5JQ.
Primary percutaneous coronary intervention (PPCI) remains the gold-standard treatment for ST- elevation myocardial infarction (STEMI). Femoral arterial access for the procedure may be an ideal option in patients who are haemodynamically unwell. However, it is associated with rare, but life- threatening, complications such as perforation, leading to retroperitoneal haemorrhage.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!